iiinova — where your digital self keeps evolving

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 12/08/2026

Join in on our next CPC - focusing on potential ID challenges of transplant tourism! Wed Sept 2 @ 7am EST, 2pm Riyadh A great interactive case discussion with expert education. @bradgardiner.bsky.social @kottonnelson.bsky.social @tidsection.bsky.social tts.org/component/co...

031

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 27/05/2026

It’s pretty standard practice and great move for transparency.

020

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 23/04/2026

ESGICH is trying to learn about what local/regional Immunocompromised Host ID Networks that hold meetings to share challenging cases or other info. If you participate in these or don’t have access to one and would want to - please complete the survey. forms.gle/jTUoweU1ebu8...

forms.gle

ESGICH Local or Regional Immunocompromised ID Networks Survey

Having forums to discuss challenging cases or novel approaches to the diagnosis and treatment of infections in immunocompromised patients are critical. There are a number of local and regional networ...

021

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 30/03/2026

On behalf of the TID section of TTS, ESGICH and the @thetxidjournal.bsky.social we invite you to: ESGICH – CPC Webinar: Thursday, April 9, 2026, at 14:00 CET  A Neglected Tropical Disease Beyond Endemic Borders: A Case-Based Discussion Registration link: us06web.zoom.us/webinar/regi...

040

Reposted by Michael G. Ison, MD MS

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 21/03/2026

Submit Ideas for Potential ESGICH Sessions at ESCMID Global 2027: If you have ideas for sessions, even if attend the in person meeting, please submit the ideas online . You can submit ideas by close of business April 17 via this link: forms.gle/ecb4ZrJkK9F3... 3/3

forms.gle

ESGICH ESCMID Global 2027 Session Concept Submission Form

Please use this form for ideas for sessions at ESCMID Global 2027. These must be submitted by April 17, 2026 5pm CET so that we can discuss them at our in person/Zoom planning meeting.

011

Reposted by Michael G. Ison, MD MS

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 21/03/2026

Participate in the Session Brainstorming Session: Sunday April 19 at 10:30am – 12:30pm in ICM 2nd Floor, Ostersee Room. A Zoom link will be shared shortly. If you want to participate in this session, please sign up using this link: forms.gle/vNnPYFuifXUH... 2/3

forms.gle

ESGICH Planning Committee for 2027 ESCMID Global

This will be a small working group to help develop proposals for ESGICH to propose for the 2027 ESCMID Global Program. The group will brainstorm in person at ESCMID Global in Munich: Sunday April 1...

121

Reposted by Michael G. Ison, MD MS

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 21/03/2026

ESGICH is seeking help in developing proposals for @escmid.bsky.social Global 2027. We are seeking participation in a brainstorming session in Munich April 19 10:30am - 12:30pm in Ostersee Room, 2nd Floor of the ICM. We are also seeking ideas for sessions. See next tweets w/ details 1/3

132

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 21/03/2026

forms.gle

ESGICH ESCMID Global 2027 Session Concept Submission Form

Please use this form for ideas for sessions at ESCMID Global 2027. These must be submitted by April 17, 2026 5pm CET so that we can discuss them at our in person/Zoom planning meeting.

011

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 21/03/2026

forms.gle

ESGICH Planning Committee for 2027 ESCMID Global

121

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 21/03/2026

132

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 02/03/2026

3 years ago, I was in the Community of Leaders group and can say it had such a huge impact on how I lead - I recommend this to anyone who wants to be a more engaged and effective leader! Time well spent!

000

Reposted by Michael G. Ison, MD MS

Erik Karlsson @eakarlsson.bsky.social · 14/02/2026

First human #H5N1 case of 2026 in #Cambodia: a 30-year-old man from Kampot province. Sequencing, virus isolation & animal investigations ongoing. Dead chicken at home before onset. Patient has since recovered. 🦠💉😷🐓🥼🔬🧪 Sequencing, contact tracing, and poultry investigations ongoing.

11512

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 12/12/2025

It’s actually hard to get the vaccine - we got ours but it required pre-paying for the doses and having delays in getting them delivered to the pharmacy. Total cost $900 with GoodRx and 3 doses so takes time. Doable but expensive and takes a lot of effort to arrange (in my experience).

130

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 15/11/2025

I had the HUGE honor of being the 40th Forbes Fellow - when I was the previous awardees, I was truly humbled. The ID community is incredible in Melbourne. @monashuniversity.bsky.social @unimelb.bsky.social @thedohertyinst.bsky.social @trubianojason.bsky.social @bradgardiner.bsky.social

1122

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 22/10/2025

Two trials on lenacapravir for prevention of HIV www.nejm.org/doi/full/10.... www.nejm.org/doi/10.1056/... Two trials on high dose influenza vaccine jamanetwork.com/journals/jam... www.nejm.org/doi/abs/10.1... www.nejm.org/doi/abs/10.1...

nejm.org

Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons | NEJM

Twice-yearly subcutaneous lenacapavir has been shown to be efficacious for prevention of human immunodeficiency virus (HIV) infection in cisgender women. The efficacy of lenacapavir for preexposure...

152

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 22/10/2025

Due to the USG Shutdown, I wasn’t able to attend or present @idweek.bsky.social. I was supposed to give the talk on top viral studies that will impact your practice. Here are the papers I was going to highlight: See next posts

53514

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 21/10/2025

Thanks to Lara Danziger-Isakov for doing the talk. Slides: www.dropbox.com/scl/fi/nj1z8...

dropbox.com

050

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 21/10/2025

Due to the US Government Shutdown, I will not be able to atted @IDWeek.bsky.social #IDWeek2025. I had worked on my 2 invited talks and so will share them. My first talk was going to be about the epidemiology and clinical course of respiratory viral infections in the immunocompromised.

1132

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 26/09/2025

Do you focus on HSCT/Oncology ID? Want to be part of the editorial team of @thetxidjournal.bsky.social? Please apply by October 17 for an open position as outlined in this link!

181

Reposted by Michael G. Ison, MD MS

Brad Gardiner @bradgardiner.bsky.social · 03/09/2025

check out our review of donor-derived infections in heart & lung transplant recipients! was a pleasure working with @michaelisonmd.bsky.social on this! #TxID doi.org/10.1016/j.jh...

doi.org

Redirecting

041

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 17/09/2025

The ISRV AVG meeting kicked of by Fred Hayden giving the 2nd Roberts/Tisdale lecture on the clinical implications of antiviral resistance.

260

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 15/08/2025

Excited to have this paper out! Demonstrates that the recipients of lung 🫁 tx for COVID-Associated Lung Injury (CALI) loose humoral protection and have unique cellular immune responses. www.sciencedirect.com/science/arti...

sciencedirect.com

Identification of immune signatures associated with both SARS-CoV-2 infection and lung transplantation

Lung transplantation (lung-tx) offers the last life-saving option for patients with COVID-19-associated lung injury (CALI). We show that the RBD-speci…

031

Reposted by Michael G. Ison, MD MS

American Journal of Transplantation @amjtransplant.bsky.social · 10/07/2025

AJT’S new ID blog, TxIDExchange, is dedicated to sharing the latest ID updates, research, and guidelines relevant to the transplant community. We’re soliciting blog posts and comments from you and your colleagues and encourage you to participate. ajt-transplant-id-exchange.squarespace.com

098

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 14/05/2025

Michael Woodward presented on utility of FMT in ICHs - can reduce risk of recurrent C diff and MDRO infections - cost, availability and lack of guidance are limiting application @fredhutch 5th Symposium on ID in ICHs. www.science.org/doi/10.1126/...

1131

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 14/05/2025

Likewise, screening for FQ resistance may inform what breakthrough infections will occur and optimize early management.

020

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 14/05/2025

Mike Satlin gave an incredible review of MDR-GBR. These challenging bacteria cause freq infections and screening for can inform management of F&N @fredhutch.bsky.social 5th Symposium on ID in ICHs.

2111

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 14/05/2025

Jay Fishman provided the keynote on Xenotransplantation- major progress but many unknowns- thankfully formal clinical trials will help inform optimal approach @fredhutch.bsky.social 5th Symposium on ID in ICHs.

061

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 13/05/2025

Erika Kampouri provided a masterful review of infections after CAR-T and the impact of CMV and HHV6 in these patients - HHV6 CNS disease rare, CMV needs more data to confirm optimal management. @fredhutch.bsky.social 5th Symposium on ID in ICHs onlinelibrary.wiley.com/doi/10.1111/...

1132

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 13/05/2025

The future may be using the tool to look at pathogen and host response in the same assay - multiple examples shown that the combined approach provided answers that wouldn’t have been identified.

140

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 13/05/2025

Charles Chiu @UCSF gave an amazing lecture on mNGS in immunocompromised- while helpful, limitations exist and must be recognized to interpret the results.

162

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 12/05/2025

Amazing talk on aging and infection Maheen Abidi - many questions and need for data to inform management approaches. @fredhutch.bsky.social Symposium of Infections in ICH

070

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 12/05/2025

Hans Hirsch provided a master class in BKV as the keynote for the 5th @fredhutch.bsky.social Symposium on Infections in ICH. Studies have advanced our understanding of pathogens and management - but many questions remain.

163

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 12/05/2025

Michael Boeckh highlights the grow of the the @fredhutch Symposium on Infections - matching interest the field of #TxID It’s easy to see why with an expansion of tools to study and apply to improve outcomes in our patients!

1112

Reposted by Michael G. Ison, MD MS

ID Chief @ UMich @adamlauring.bsky.social · 23/04/2025

Really excited to be a part of this study and see it published today! Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza | New England Journal of Medicine www.nejm.org/doi/full/10....

nejm.org

Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza | NEJM

Baloxavir marboxil (baloxavir) rapidly reduces influenza virus shedding, which suggests that it may reduce transmission. Studies of treatment with neuraminidase inhibitors have not shown sufficient...

25314

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 16/04/2025

Adjuvanted RSV profusion F vaccine protection over 3 years - while VE declined over time, there remains significant protection against severe disease. More data is needed for longer term outcomes to inform optimal use.

041

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 12/04/2025

It was an honor to review the data on the link between Ureaplasma spp and Hyperammonemia in Lung Transplant recipients @ESCMID #ESCMIDGlobal 2025. Slides are here for those who want them. www.dropbox.com/scl/fi/ei4ym...

dropbox.com

0102

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 12/04/2025

A true master class on Chagas in transplantation - emerging data supports the safety of using Chagas positive donors with careful monitoring and treatment. Marcelo Radisic #ESCMIDGlobal

051

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 12/04/2025

Great review of TB in endemic regions including approaches to use universal prophylaxis to reduce the incidence of post-transplant infection. @RubinaNaqvi1

010